Scientists are using ancient DNA and gene editing to bring back woolly mammoths—possibly by 2028. This controversial project ...

His case changed when KNH invited him to join the TSR surgical camp between April 28 and May 2, offering him a chance to ...

Learn how Canada is speaking against naked short selling, a practice that distorts markets and erodes trust among investors.

Persona 5: The Phantom X, the spin-off mobile and PC game, now has a global release date. As revealed in a livestream today, the free-to-play game will release globally on 26th June and will be ...

Taiwan-based production banner D-Day Pictures and Singapore’s Mokster Films have teamed on “Phantom,” an Eastern Taoist-infused take on the “Invisible Man” concept, unveiled at this year ...

Atlus, however, isn't quite done with its predecessor, as we return to Tokyo for Persona 5: The Phantom X, a new JRPG that will be launching globally in June as a free PC game. Originally only ...

Industry layoffs continue to accelerate, this time hitting RA Capital’s biotech incubator, according to Stat. RA Ventures, also known as Raven, is a healthcare accelerator for the prominent life ...

Marc "Spidey" Griffin has been an established gaming and entertainment journalist and associate editor since 2019. He has written for the likes of Grammy.com/The ...

Free-to-play RPG Persona 5: The Phantom X will launch for PC via Steam, iOS via App Store, and Android via Google Play on June 26 in the west and Japan, publisher ATLUS and developer Black Wings ...

While Persona 5: The Phantom X does include references to both Persona 5 and Persona 5 Royal and allows those characters to be recruited via the gacha, this free-to-play game features an original ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

LONDON (Reuters) -Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs ...